REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Granula Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: GRANULA Kereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Granula Bt. is a company in Hungary, with a head office in Nyirkarasz. It operates in the Pharmacies and Drug Stores industry. It was first established on November 30, 1995. It currently has a total number of 4 (2024) employees. From the latest financial highlights, Granula Bt. reported a net sales revenue increase of 1.98% in 2023. During that time, Granula Bt.’s total assets grew by 15.53%. In 2023, Granula Bt.’s net profit margin increased by 2.12%.

Headquarters
Kossuth u.1.
Nyirkarasz; Szabolcs-Szatmar-Bereg; Postal Code: 4544

Contact Details: Purchase the Granula Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Granula Bt. report to view the information.
Outstanding Shares:
Purchase the Granula Bt. report to view the information.
Registered Capital:
Purchase the Granula Bt. report to view the information.
Financial Auditors:
Purchase the Granula Bt. report to view the information.
Incorporation Date:
November 30, 1995
Key Executives
Purchase this report to view the information.
Business Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Viridis-Pharma Kft.
Company Performance
Financial values in the chart are available after Granula Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
1.98%▲
Total operating revenue
2.92%▲
Operating profit (EBIT)
104.96%▲
EBITDA
83.4%▲
Net Profit (Loss) for the Period
105.21%▲
Total assets
15.53%▲
Total equity
26.62%▲
Operating Profit Margin (ROS)
2.33%▲
Net Profit Margin
2.12%▲
Return on Equity (ROE)
8.05%▲
Quick Ratio
-0.26%▼
Cash Ratio
-0.22%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo